Decreased serum concentrations of sphingosine-1-phosphate in sepsis

Standard

Decreased serum concentrations of sphingosine-1-phosphate in sepsis. / Winkler, Martin Sebastian; Nierhaus, Axel; Holzmann, Maximilian; Mudersbach, Eileen; Bauer, Antonia; Robbe, Linda; Zahrte, Corinne; Geffken, Maria ; Peine, Sven; Schwedhelm, Edzard; Daum, Günter; Kluge, Stefan; Zoellner, Christian.

in: CRIT CARE, Jahrgang 19, Nr. 1, 26.10.2015, S. 372.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Winkler, MS, Nierhaus, A, Holzmann, M, Mudersbach, E, Bauer, A, Robbe, L, Zahrte, C, Geffken, M, Peine, S, Schwedhelm, E, Daum, G, Kluge, S & Zoellner, C 2015, 'Decreased serum concentrations of sphingosine-1-phosphate in sepsis', CRIT CARE, Jg. 19, Nr. 1, S. 372. https://doi.org/10.1186/s13054-015-1089-0

APA

Winkler, M. S., Nierhaus, A., Holzmann, M., Mudersbach, E., Bauer, A., Robbe, L., Zahrte, C., Geffken, M., Peine, S., Schwedhelm, E., Daum, G., Kluge, S., & Zoellner, C. (2015). Decreased serum concentrations of sphingosine-1-phosphate in sepsis. CRIT CARE, 19(1), 372. https://doi.org/10.1186/s13054-015-1089-0

Vancouver

Winkler MS, Nierhaus A, Holzmann M, Mudersbach E, Bauer A, Robbe L et al. Decreased serum concentrations of sphingosine-1-phosphate in sepsis. CRIT CARE. 2015 Okt 26;19(1):372. https://doi.org/10.1186/s13054-015-1089-0

Bibtex

@article{68f1c84ab5fc48c2b9e39599fd9cc918,
title = "Decreased serum concentrations of sphingosine-1-phosphate in sepsis",
abstract = "INTRODUCTION: Sphingosine-1-phosphate (S1P) is a signaling lipid that regulates pathophysiological processes involved in sepsis progression, including endothelial permeability, cytokine release, and vascular tone. The aim of this study was to investigate whether serum-S1P concentrations are associated with disease severity in patients with sepsis.METHODS: This single-center prospective-observational study includes 100 patients with systemic inflammatory response syndrome (SIRS) plus infection (n = 40), severe sepsis (n = 30), or septic shock (n = 30) and 214 healthy blood donors as controls. Serum-S1P was measured by mass spectrometry. Blood parameters, including C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), lactate, and white blood cells (WBCs), were determined by routine assays. The Sequential Organ Failure Assessment (SOFA) score was generated and used to evaluate disease severity.RESULTS: Serum-S1P concentrations were lower in patients than in controls (P < 0.01), and the greatest difference was between the control and the septic shock groups (P < 0.01). Serum-S1P levels were inversely correlated with disease severity as determined by the SOFA score (P < 0.01) as well as with IL-6, PCT, CRP, creatinine, lactate, and fluid balance. A receiver operating characteristic analysis for the presence or absence of septic shock revealed equally high sensitivity and specificity for S1P compared with the SOFA score. In a multivariate logistic regression model calculated for prediction of septic shock, S1P emerged as the strongest predictor (P < 0.001).CONCLUSIONS: In patients with sepsis, serum-S1P levels are dramatically decreased and are inversely associated with disease severity. Since S1P is a potent regulator of endothelial integrity, low S1P levels may contribute to capillary leakage, impaired tissue perfusion, and organ failure in sepsis.",
author = "Winkler, {Martin Sebastian} and Axel Nierhaus and Maximilian Holzmann and Eileen Mudersbach and Antonia Bauer and Linda Robbe and Corinne Zahrte and Maria Geffken and Sven Peine and Edzard Schwedhelm and G{\"u}nter Daum and Stefan Kluge and Christian Zoellner",
year = "2015",
month = oct,
day = "26",
doi = "10.1186/s13054-015-1089-0",
language = "English",
volume = "19",
pages = "372",
journal = "CRIT CARE",
issn = "1364-8535",
publisher = "Springer Science + Business Media",
number = "1",

}

RIS

TY - JOUR

T1 - Decreased serum concentrations of sphingosine-1-phosphate in sepsis

AU - Winkler, Martin Sebastian

AU - Nierhaus, Axel

AU - Holzmann, Maximilian

AU - Mudersbach, Eileen

AU - Bauer, Antonia

AU - Robbe, Linda

AU - Zahrte, Corinne

AU - Geffken, Maria

AU - Peine, Sven

AU - Schwedhelm, Edzard

AU - Daum, Günter

AU - Kluge, Stefan

AU - Zoellner, Christian

PY - 2015/10/26

Y1 - 2015/10/26

N2 - INTRODUCTION: Sphingosine-1-phosphate (S1P) is a signaling lipid that regulates pathophysiological processes involved in sepsis progression, including endothelial permeability, cytokine release, and vascular tone. The aim of this study was to investigate whether serum-S1P concentrations are associated with disease severity in patients with sepsis.METHODS: This single-center prospective-observational study includes 100 patients with systemic inflammatory response syndrome (SIRS) plus infection (n = 40), severe sepsis (n = 30), or septic shock (n = 30) and 214 healthy blood donors as controls. Serum-S1P was measured by mass spectrometry. Blood parameters, including C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), lactate, and white blood cells (WBCs), were determined by routine assays. The Sequential Organ Failure Assessment (SOFA) score was generated and used to evaluate disease severity.RESULTS: Serum-S1P concentrations were lower in patients than in controls (P < 0.01), and the greatest difference was between the control and the septic shock groups (P < 0.01). Serum-S1P levels were inversely correlated with disease severity as determined by the SOFA score (P < 0.01) as well as with IL-6, PCT, CRP, creatinine, lactate, and fluid balance. A receiver operating characteristic analysis for the presence or absence of septic shock revealed equally high sensitivity and specificity for S1P compared with the SOFA score. In a multivariate logistic regression model calculated for prediction of septic shock, S1P emerged as the strongest predictor (P < 0.001).CONCLUSIONS: In patients with sepsis, serum-S1P levels are dramatically decreased and are inversely associated with disease severity. Since S1P is a potent regulator of endothelial integrity, low S1P levels may contribute to capillary leakage, impaired tissue perfusion, and organ failure in sepsis.

AB - INTRODUCTION: Sphingosine-1-phosphate (S1P) is a signaling lipid that regulates pathophysiological processes involved in sepsis progression, including endothelial permeability, cytokine release, and vascular tone. The aim of this study was to investigate whether serum-S1P concentrations are associated with disease severity in patients with sepsis.METHODS: This single-center prospective-observational study includes 100 patients with systemic inflammatory response syndrome (SIRS) plus infection (n = 40), severe sepsis (n = 30), or septic shock (n = 30) and 214 healthy blood donors as controls. Serum-S1P was measured by mass spectrometry. Blood parameters, including C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), lactate, and white blood cells (WBCs), were determined by routine assays. The Sequential Organ Failure Assessment (SOFA) score was generated and used to evaluate disease severity.RESULTS: Serum-S1P concentrations were lower in patients than in controls (P < 0.01), and the greatest difference was between the control and the septic shock groups (P < 0.01). Serum-S1P levels were inversely correlated with disease severity as determined by the SOFA score (P < 0.01) as well as with IL-6, PCT, CRP, creatinine, lactate, and fluid balance. A receiver operating characteristic analysis for the presence or absence of septic shock revealed equally high sensitivity and specificity for S1P compared with the SOFA score. In a multivariate logistic regression model calculated for prediction of septic shock, S1P emerged as the strongest predictor (P < 0.001).CONCLUSIONS: In patients with sepsis, serum-S1P levels are dramatically decreased and are inversely associated with disease severity. Since S1P is a potent regulator of endothelial integrity, low S1P levels may contribute to capillary leakage, impaired tissue perfusion, and organ failure in sepsis.

U2 - 10.1186/s13054-015-1089-0

DO - 10.1186/s13054-015-1089-0

M3 - SCORING: Journal article

C2 - 26498205

VL - 19

SP - 372

JO - CRIT CARE

JF - CRIT CARE

SN - 1364-8535

IS - 1

ER -